The goal of this interventional non-pharmacological study is to evaluate, using a multimodal approach, the progression of autonomic and sensory involvement in in amyotrophic lateral sclerosis (ALS) patients enrolled within 18 months from motor onset and its relationship with the progression of overall clinical disability. The main questions it aims to answer are: * Is autonomic dysfunction at diagnosis associated with disease progression and survival in patients with Amyotrophic Lateral Sclerosis ? * Can we identify in the skin biomarkers to be used as reliable measures of disease progression and to apply in future clinical trials for patient stratification and to assess response to drug treatment ? Participants at time 0 will receive a full clinical and instrumental examination and a blood sample testing to check inclusion and exclusion criteria, genetic screening for the most common genes associated with ALS (SOD1, FUS, TARDBP and c9orf72), questionnaires about clinical characteristics, quality of life, pain and a multidomain battery of neuropsychological tests, multimodal assessment of the autonomic nervous system including skin biopsy for morphological study. At follow-up we'll perform clinical scales and skin biopsy. Researchers will compare results from ALS patients with data obtained from a population of age and sex matched healthy subjects.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
100
A punch skin biopsy of 3mm will be used to analyze cutaneous innervation
Cardiovascular reflex tests including deep breathing, head-up Tilt, standing, isometric exercises, mental arithmetic and Valsalva maneuver.
We'll characterize patients' symptoms through the administration of clinical scales such as: SCOPA-AUT autonomic symptoms scale; Brief Pain Inventory questionnaire
Test for the functional assessment of postganglionic sudomotor pathway
ICS Maugeri - IRCCS of Telese Terme
Telese Terme, Benevento, Italy
RECRUITINGDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II
Napoli, Italy
RECRUITINGSensory peripheral innervation (IENF)
Quantification Intraepidermal Nerve Fibers (IENF ff/mm) in skin biopsy from fingertip, thigh and leg.
Time frame: At recruitment
Autonomic peripheral innervation
Quantification of nerves in sweat gland (fiber lenght/um3) in skin biopsy from fingertip, thigh and leg. Quantification of nerves in arrector pili muscle (ff/mm) in skin biopsy from thigh and leg.
Time frame: At recruitment
Autonomic peripheral innervation
Quantification sweat gland (fiber lenght/um3) and arrector pili muscle (ff/mm) innervation in skin biopsy from thigh.
Time frame: At follow-up, an average of 6 months
Sensory peripheral innervation (IENF)
Quantification Intraepidermal Nerve Fibers (IENF ff/mm) in skin biopsy from thigh.
Time frame: At follow-up, an average of 6 months
Sensory and autonomic symptoms evaluated by clinical scales
Data of sensory and autonomic symptoms (Small fiber neuropathy Symptoms inventory questionnaire (SFN-SIQ) and Scale for Outcomes in Parkinson's disease for Autonomic Symptoms (SCOPA AUT)) will be collected
Time frame: At the recruitment
Sensory and autonomic symptoms evaluated by clinical scales
Data of sensory and autonomic symptoms (Small fiber neuropathy Symptoms inventory questionnaire (SFN-SIQ) and Scale for Outcomes in Parkinson's disease for Autonomic Symptoms (SCOPA AUT)) will be collected
Time frame: At follow-up, an average of 6 months
Assessment of Cardiovascular function
Data from cardiovascular reflex test will be analyzed and compared with morphological data and clinical motor severity
Time frame: baseline
Sudomotor function
Data from dinamic sweat test will be analyzed and compared with morphological data and clinical motor severity
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.